CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Assertio Holdings, Inc. - ASRT CFD

0.8067
6.25%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.0193
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Assertio Holdings Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 0.8605
Open* 0.8624
1-Year Change* -86.25%
Day's Range* 0.7933 - 0.8624
52 wk Range 0.78-8.01
Average Volume (10 days) 1.56M
Average Volume (3 months) 32.22M
Market Cap 77.47M
P/E Ratio -100.00K
Shares Outstanding 94.67M
Revenue 169.43M
EPS -2.05
Dividend (Yield %) N/A
Beta 0.98
Next Earnings Date Mar 6, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 15, 2024 0.8067 -0.0557 -6.46% 0.8624 0.8677 0.7933
Apr 12, 2024 0.8605 -0.0028 -0.32% 0.8633 0.8823 0.8523
Apr 11, 2024 0.8746 -0.0154 -1.73% 0.8900 0.8923 0.8723
Apr 10, 2024 0.8828 -0.0095 -1.06% 0.8923 0.8978 0.8723
Apr 9, 2024 0.8995 -0.0228 -2.47% 0.9223 0.9424 0.8923
Apr 8, 2024 0.9151 -0.0332 -3.50% 0.9483 0.9483 0.9023
Apr 5, 2024 0.9401 0.0378 4.19% 0.9023 0.9401 0.8923
Apr 4, 2024 0.9155 -0.0184 -1.97% 0.9339 0.9339 0.8923
Apr 3, 2024 0.9123 -0.0002 -0.02% 0.9125 0.9305 0.8772
Apr 2, 2024 0.9292 0.0009 0.10% 0.9283 0.9303 0.9028
Apr 1, 2024 0.9241 -0.0282 -2.96% 0.9523 0.9523 0.8779
Mar 28, 2024 0.9475 -0.0448 -4.51% 0.9923 1.0023 0.9423
Mar 27, 2024 0.9779 -0.0344 -3.40% 1.0123 1.0423 0.9724
Mar 26, 2024 1.0123 0.0000 0.00% 1.0123 1.0423 1.0123
Mar 25, 2024 1.0323 0.0200 1.98% 1.0123 1.0723 1.0023
Mar 22, 2024 1.0323 0.0200 1.98% 1.0123 1.0423 0.9923
Mar 21, 2024 1.0323 -0.0100 -0.96% 1.0423 1.0523 1.0023
Mar 20, 2024 1.0323 0.0400 4.03% 0.9923 1.0623 0.9433
Mar 19, 2024 0.9923 -0.0400 -3.87% 1.0323 1.0323 0.9723
Mar 18, 2024 1.0223 -0.0700 -6.41% 1.0923 1.1123 1.0223

Assertio Holdings, Inc. Events

Time (UTC) Country Event
Tuesday, May 7, 2024

Time (UTC)

12:30

Country

US

Event

Q1 2024 Assertio Holdings Inc Earnings Release
Q1 2024 Assertio Holdings Inc Earnings Release

Forecast

-

Previous

-
Thursday, May 9, 2024

Time (UTC)

17:30

Country

US

Event

Assertio Holdings Inc Annual Shareholders Meeting
Assertio Holdings Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Monday, May 13, 2024

Time (UTC)

12:00

Country

US

Event

Assertio Holdings Inc at Citizens JMP Life Sciences Conference
Assertio Holdings Inc at Citizens JMP Life Sciences Conference

Forecast

-

Previous

-
Thursday, May 23, 2024

Time (UTC)

17:30

Country

US

Event

Assertio Holdings Inc Annual Shareholders Meeting
Assertio Holdings Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Thursday, August 1, 2024

Time (UTC)

10:59

Country

US

Event

Q2 2024 Assertio Holdings Inc Earnings Release
Q2 2024 Assertio Holdings Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 156.234 111.014 106.275 229.504 311.77
Revenue 156.234 111.014 106.275 229.504 311.77
Cost of Revenue, Total 17.948 15.232 15.772 9.505 18.476
Gross Profit 138.286 95.782 90.503 219.999 293.294
Total Operating Expense 116.829 101.59 132.637 397.547 206.111
Selling/General/Admin. Expenses, Total 45.986 56.555 105.323 108.866 119.218
Research & Development 0 4.213 10.106 8.042
Depreciation / Amortization 33.408 28.114 24.783 101.774 101.774
Unusual Expense (Income) 0.8 1.689 -17.454 167.296 -41.399
Operating Income 39.405 9.424 -26.362 -168.043 105.659
Interest Income (Expense), Net Non-Operating -7.961 -10.22 -15.926 -58.389 -68.881
Other, Net -0.278 0.243 -3.225 3.948 1.197
Net Income Before Taxes 31.166 -0.553 -45.513 -222.484 37.975
Net Income After Taxes 109.625 -1.281 -28.144 -217.201 36.908
Net Income Before Extra. Items 109.625 -1.281 -28.144 -217.201 36.908
Net Income 109.625 -1.281 -28.144 -217.201 36.908
Income Available to Common Excl. Extra. Items 109.625 -1.281 -28.144 -217.201 36.908
Income Available to Common Incl. Extra. Items 109.625 -1.281 -28.144 -217.201 36.908
Dilution Adjustment
Diluted Net Income 109.625 -1.281 -28.144 -217.201 36.908
Diluted Weighted Average Shares 54.669 43.169 26.2087 17.679 16.052
Diluted EPS Excluding Extraordinary Items 2.00525 -0.02967 -1.07384 -12.2858 2.29928
Diluted Normalized EPS 2.01476 -0.00424 -1.50671 -6.13488 0.62289
Total Extraordinary Items
Interest Expense (Income) - Net Operating 18.687
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 40.991 42.466 50.35 34.212 35.131
Revenue 40.991 42.466 50.35 34.212 35.131
Cost of Revenue, Total 4.772 5.267 5.914 4.009 4.228
Gross Profit 36.219 37.199 44.436 30.203 30.903
Total Operating Expense 28.571 47.74 39.728 27.778 24.34
Selling/General/Admin. Expenses, Total 16.571 16.704 13.502 11.7 10.343
Research & Development 0.503
Depreciation / Amortization 6.484 6.484 8.37 8.169 8.169
Unusual Expense (Income) 10.118 0.1 0 0.3
Operating Income 12.42 -5.274 10.622 6.434 10.791
Interest Income (Expense), Net Non-Operating -0.751 -1.122 -1.313 -2.052 -2.269
Other, Net 0.661 0.802 -0.731 0.002 -0.095
Net Income Before Taxes 12.33 -5.594 8.578 4.384 8.427
Net Income After Taxes 8.47 -3.484 88.553 4.174 7.834
Net Income Before Extra. Items 8.47 -3.484 88.553 4.174 7.834
Net Income 8.47 -3.484 88.553 4.174 7.834
Income Available to Common Excl. Extra. Items 8.47 -3.484 88.553 4.174 7.834
Income Available to Common Incl. Extra. Items 8.47 -3.484 88.553 4.174 7.834
Diluted Net Income 8.47 -3.484 88.553 4.174 7.834
Diluted Weighted Average Shares 70.144 51.005 67.266 57.386 47.579
Diluted EPS Excluding Extraordinary Items 0.12075 -0.06831 1.31646 0.07274 0.16465
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS 0.12075 0.06064 1.31743 0.07274 0.17051
Interest Expense (Income) - Net Operating 0.241 9.167 11.842 3.9 1.3
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 132.262 103.498 94.254 103.951 208.107
Cash and Short Term Investments 64.941 36.81 20.786 42.107 110.949
Cash & Equivalents 64.941 36.81 20.786 42.107 110.949
Short Term Investments 0
Total Receivables, Net 45.357 44.361 44.35 43.544 37.211
Accounts Receivable - Trade, Net 45.357 44.361 44.35 43.257 37.211
Total Inventory 13.696 7.489 11.712 3.412 3.396
Prepaid Expenses 8.268 14.838 17.406 14.888 56.551
Total Assets 413.913 326.547 303.274 527.17 932.866
Property/Plant/Equipment, Total - Net 0.881 2.262 4.784 6.273 13.064
Property/Plant/Equipment, Total - Gross 4.814 14.011 15.57 18.143 23.837
Accumulated Depreciation, Total -3.933 -11.749 -10.786 -11.87 -10.773
Intangibles, Net 197.996 216.054 200.082 400.535 692.099
Other Long Term Assets, Total 82.506 3.154 2.575 2.247 7.812
Total Current Liabilities 95.316 135.019 132.686 184.553 246.036
Accounts Payable 5.991 6.685 14.808 16.193 6.138
Accrued Expenses 62.008 69.339 99.161 88.36 118.765
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 26.847 46.821 6.775 1.133
Total Liabilities 188.188 224.133 247.76 469.212 712.531
Total Long Term Debt 66.403 61.319 72.16 271.258 446.107
Long Term Debt 66.403 61.319 72.16 271.258 446.107
Other Liabilities, Total 26.469 27.795 42.914 13.401 20.388
Total Equity 225.725 102.414 55.514 57.958 220.335
Preferred Stock - Non Redeemable, Net
Common Stock 0.005 0.004 0.013 0.008 0.006
Additional Paid-In Capital 545.321 531.636 483.446 457.751 402.934
Retained Earnings (Accumulated Deficit) -319.601 -429.226 -427.945 -399.801 -182.6
Other Equity, Total 0 -0.005
Total Liabilities & Shareholders’ Equity 413.913 326.547 303.274 527.17 932.866
Total Common Shares Outstanding 48.3198 44.6404 28.3922 20.222 16.0463
Long Term Investments 0.268 1.579 1.579 13.064 11.784
Current Port. of LT Debt/Capital Leases 0.47 12.174 11.942 80 120
Note Receivable - Long Term 1.1
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 184.96 133.549 137.849 132.262 126.494
Cash and Short Term Investments 76.888 70.175 68.603 64.941 64.826
Cash & Equivalents 76.888 70.175 68.603 64.941 64.826
Total Receivables, Net 62.467 41.608 46.466 45.357 44.68
Accounts Receivable - Trade, Net 62.467 41.608 46.466 45.357 42.061
Total Inventory 42.71 18.817 16.226 13.696 14.268
Prepaid Expenses 2.895 2.949 6.554 8.268 2.72
Total Assets 380.028 405.179 414.274 413.913 323.344
Property/Plant/Equipment, Total - Net 2.61 2.206 0.651 0.881 1.197
Property/Plant/Equipment, Total - Gross 7.107 6.53 4.78 4.814 12.422
Accumulated Depreciation, Total -4.497 -4.324 -4.129 -3.933 -11.225
Intangibles, Net 170.413 185.428 191.712 197.996 191.617
Other Long Term Assets, Total 2.189 83.996 84.062 82.506 2.457
Total Current Liabilities 114.289 79.478 94.545 95.316 92.296
Accounts Payable 19.004 11.182 6.173 5.991 8.374
Accrued Expenses 81.106 53.369 63.418 62.008 59.923
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 0 0.47 0.47 2.175
Other Current Liabilities, Total 14.179 14.927 24.484 26.847 21.824
Total Liabilities 187.155 150.908 163.61 188.188 188.429
Total Long Term Debt 38.866 38.251 38.151 66.403 65.982
Long Term Debt 38.866 38.251 38.151 66.403 65.982
Other Liabilities, Total 34 33.179 30.914 26.469 30.151
Total Equity 192.873 254.271 250.664 225.725 134.915
Common Stock 0.009 0.005 0.005 0.005 0.005
Additional Paid-In Capital 787.023 568.881 573.744 545.321 543.064
Retained Earnings (Accumulated Deficit) -594.159 -314.615 -323.085 -319.601 -408.154
Total Liabilities & Shareholders’ Equity 380.028 405.179 414.274 413.913 323.344
Total Common Shares Outstanding 94.553 56.513 55.6619 48.3198 48.1966
Long Term Investments 0.268 1.579
Goodwill, Net 19.856
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 109.625 -1.281 -28.144 -217.201 36.908
Cash From Operating Activities 78.598 5.523 -65.572 90.475 72.497
Cash From Operating Activities 33.396 29.077 26.431 102.946 106.426
Deferred Taxes -80.375 0
Non-Cash Items 28.966 9.02 -19.647 205.336 36.361
Cash Taxes Paid -6.913 0 1.136 4.401 6.472
Cash Interest Paid 7.752 10.124 17.598 37.788 48.44
Changes in Working Capital -13.014 -31.293 -44.212 -0.606 -107.198
Cash From Investing Activities -42.673 -18.525 512.801 -1.481 -7.082
Capital Expenditures -15.646 -0.053 -0.01 -1.481 -5.507
Other Investing Cash Flow Items, Total -27.027 -18.472 512.811 0 -1.575
Cash From Financing Activities -7.794 29.026 -468.55 -157.836 -81.35
Financing Cash Flow Items -14.098 -6.193 -4.382 -8.087 -0.87
Issuance (Retirement) of Stock, Net 7.054 45.054 0.088 0.251 2.02
Issuance (Retirement) of Debt, Net -0.75 -9.835 -464.256 -150 -82.5
Net Change in Cash 28.131 16.024 -21.321 -68.842 -15.935
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -3.484 109.625 21.072 16.898 9.064
Cash From Operating Activities 22.717 78.598 51.901 41.856 27.426
Cash From Operating Activities 6.484 33.396 25.033 16.863 8.699
Non-Cash Items 22.75 28.966 12.917 5.968 2.686
Cash Taxes Paid 0.029 -6.913 -7.822 -8.36 -8.36
Cash Interest Paid 2.351 7.752 7.752 4.748 0
Changes in Working Capital -1.666 -13.014 -7.121 2.127 6.977
Cash From Investing Activities -0.105 -42.673 -16.889 -16.518 -0.404
Capital Expenditures -0.105 -15.646
Cash From Financing Activities -18.95 -7.794 -6.996 -9.884 -2.443
Financing Cash Flow Items -7.331 -14.098 -9.182 -5.154 -2.443
Issuance (Retirement) of Stock, Net 7.054 7.02 7.02 0
Issuance (Retirement) of Debt, Net -11.619 -0.75 -4.834 -11.75
Net Change in Cash 3.662 28.131 28.016 15.454 24.579
Other Investing Cash Flow Items, Total 0 -27.027 -16.889 -16.518 -0.404
Deferred Taxes -1.367 -80.375

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Assertio Holdings, Inc. Company profile

Assertio Holdings, Inc., a commercial pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. The company''s pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; moderate to severe ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides CAMBIA, a non-steroidal anti-inflammatory drug (NSAID) for the treatment of migraine, nausea, photophobia, and phonophobia; Zipsor, an NSAID for relief of mild to moderate acute pain; and SPRIX, an NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 1995 and is headquartered in Lake Forest, Illinois.
Industry: Pharmaceuticals (NEC)

100 S. Saunders Road
Suite 300
LAKE FOREST
ILLINOIS 60045
US

Income Statement

  • Annual
  • Quarterly

News

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

People also watch

ETH/USD

3,087.88 Price
-0.200% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

XRP/USD

0.50 Price
-0.610% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

US100

17,747.80 Price
+0.010% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

BTC/USD

63,341.50 Price
-0.140% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading